Kerala Health Minister Demands Decade-Long Audit After Massive Medicine Waste Uncovered
Minister K. Muraleedharan has ordered an urgent investigation into the Kerala State Medical Services Corporation for systemic failures in inventory management. The probe covers ten years of procurement data to identify how massive quantities of taxpayer-funded drugs expired before reaching patients.
Key takeaways
- Health Minister K. Muraleedharan ordered a 10-year review of Kerala's medicine procurement and inventory management.
- The Kerala State Medical Services Corporation (KMSCL) faces scrutiny for allowing significant drug quantities to expire unused.
- The Principal Secretary must submit a comprehensive report with photographic evidence of expired stock within one month.
- The investigation aims to quantify financial losses to the state exchequer and identify lapses in stock rotation and redistribution.
Investigation Into Public Health Supply Chain
Kerala Health Minister K. Muraleedharan has issued a mandate to the Principal Secretary (Health) to launch a forensic review of the state's pharmaceutical supply chain. The directive, issued on July 28 and marked as most urgent, follows revelations that significant volumes of drugs purchased for public health facilities expired while sitting in storage. This waste has caused substantial financial damage to the state treasury.
SCRUTINIZING KMSCL OPERATIONS
Central to this inquiry is the Kerala State Medical Services Corporation Ltd. (KMSCL), the primary agency responsible for the purchase, storage, and distribution of medicines to government hospitals. The Minister's order requires a deep examination of how the corporation planned its procurement and managed its inventory. Investigators will look for specific failures in stock rotation and the inability to redistribute drugs nearing their expiration dates to facilities where they were needed.
Scope and Accountability
The Principal Secretary has one month to deliver a comprehensive report covering the last ten years. This document must quantify the total volume and monetary value of expired drugs, categorized by year and individual institution. Additionally, the government has requested photographic evidence of all expired stock currently held in KMSCL warehouses and hospitals. The probe will also tally the costs associated with the scientific disposal of these wasted supplies and identify the personnel or processes responsible for these lapses.
Key Facts
- Review Period: The investigation spans the last decade of pharmaceutical procurement and distribution in Kerala.
- Target Entity: Kerala State Medical Services Corporation Ltd. (KMSCL) is the primary focus of the management audit.
- Reporting Deadline: A final report with corrective recommendations is due within 30 days of the order.
- Data Requirements: The audit must include year-wise and institution-wise breakdowns of expired stock value and disposal costs.
Source: The Hindu — National
Related stories
Chief Minister Vijay Convenes State Lawmakers to Address Looming Delimitation Reforms
Bengaluru Police Recover Skeletal Remains of Woman Dead for One Year in Solitary Home
Andhra Pradesh Police Promote 181 Helpline as Integrated Support for Women in Crisis
